immunotherapy 274, 276–277,
365, 372
implantable cardioverter
defibrillator (ICD) 19, 69
incubation period 338
indoles 379t
infants
aging, changes in the blood and
lymph that occur with 123
aging, effects on immune
response 239
chlamydia 317
immunity 274
passive immunity 289
tachypnea 232
infection 338. See also specific
infections
abscess 306
active immunity 239
aging, effects on immune
response 239
antibody 245
antibody-mediated immunity
246
carrier 315
fever 326
immune response 272–273
immune system 273
immunity 273–274
inflammation 277
lymph 149
lymph node 151
lymphocytopenia 152
microbe 344
monocyte 157
nosocomial infections 347
opportunistic. Seeopportunistic
infections
infectious diseases 303–363
infectious mononucleosis. See
mononucleosis, infectious
inferior vena cava 4, 115
inflammation 277
antihistamine medications 247
atelectasis 190
atherosclerotic plaque 22
berylliosis 192
bronchitis 196
bronchus 198
COPD 199
c-reactive protein 45–46
cytokines 257
endocarditis 53–54
granuloma 265
histamine 267
immune response 273
immune system 236, 238
immunotherapy 276
infection 338
interferons 278
interleukins 278
leukotrienes 279
lung abscess 208
macrophage 282
mast cell 283
meningitis 343–344
NSAIDs 286
pericarditis 95–96
pleura 218
prostaglandins 290
rheumatoid arthritis 291–292
sarcoidosis 293–294
TGFs 297
toxic shock syndrome 357
inflammation response 136, 163
inflammatory bowel disease (IBD)
260, 297
influenza 338–340
infectious diseases 303
lung transplantation 213
NALT 288
pericarditis 95
pneumonia 220
sneeze/cough etiquette 354
vaccine 298
influenza A 221, 338
influenza B 221, 338
inheritance patterns 131, 143, 166,
169, 174, 201
innate immunity 274, 277–278
inotropics 81, 85t
insulin 8, 72–73, 90, 97, 249
insulin resistance 25, 49
interferons 276, 278,368, 372
interleukins 278
cancer treatment options and
decisions 372
fever 326
immunotherapy 276
psychoneuroimmunology 290
TGFs 297
TNFs 297
intermittent claudication 69,78,
79, 96
interstitial lung disorders 205, 226
intima 20, 44, 45, 64
intra-aortic balloon pump (IABP)
counterpulsation 70
iron 119, 125, 126, 156
ischemic heart disease (IHD) 60,
63, 70,102, 108, 111–112
ischemic stroke 107, 108, 110, 111J
joint 277, 341, 353. See also
osteoarthritis; rheumatoid
arthritisK
Kaposi’s sarcoma 95, 158, 370
Kawasaki disease 71, 300 t
kidney disease 66, 125, 138
kidneys 49, 50, 137, 359
killer T-cell 272, 296
Kupffer cells 119, 138, 157, 162L
lacrimal (tear) glands (Sjögren’s
syndrome) 294–295
LAD artery. Seeleft anterior
descending artery
Landsteiner, Karl 122, 130
Langerhans cells 157, 295
laser surgery 111–112, 115
LDL-C. Seelow-density lipoprotein
cholesterol
left anterior descending (LAD)
artery 40, 43
left atrium 4, 62, 88
left ventricle 4, 32, 40, 112
left ventricular ejection fraction
(LVEF) 45, 61, 72
Legionella pneumophila206, 303
Legionnaires’ disease 206–207,
222, 303
legs
intermittent claudication 69
pulmonary embolism 225
PVD 96–97
varicose veins 114–115
venogram 115–116
venous insufficiency 115
leukemia 145–148, 147 t
adult survivors of childhood
cancer 366, 367
B-cell lymphocyte 251
blood and lymph research and
treatment advances 122
blood disorders 121
bone marrow donation 132
cancer treatment options and
decisions 372
carcinogen 374
chemotherapy 377
CSFs 254
immunoglobulin 275
interferons 278
lymphadenopathy 149
lymphoma 155418 Index